Incretins in patients with rheumatoid arthritis

Patients and control subjects with diabetes mellitus were not included in the study. [...]none of the patients or control subjects were receiving glucose-lowering drugs or insulin therapy. [...]although the relationship of GLP-1 to HOMA-IR was found to be negative in control subjects (? coefficient ? [...]GIP response had a flatter curve in patients with RA, although statistical significance was not reached in this case (Table 5 and Fig. 1). According to our findings, incretins and DPP-4 differ in patients with RA and control subjects.